TREE NEWS reports: Moderna’s stock more than doubled after a Phase 3 trial showed its cancer vaccine outperformed the standard of care, causing short sellers to lose $4.8 billion. This is a major milestone for the biotech sector, but it is not related to crypto or RWA.
Moderna Stock Surges on Cancer Vaccine Breakthrough
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
6m ago
Horizon Robotics Aims to Top China’s Autonomous Driving Chip Market Next Year
25m ago
Yu Minhong: East Buy Plans 1,000 Physical Stores in Three Years
3h ago
US Judge Allows Pentagon to Fire Three Stars and Stripes Journalists
4h ago
Coatue in talks with MatX on chip-financing JV
5h ago
DoubleLine credit chief sees value in big tech bonds after AI selloff
5h ago
Anthropic to File IPO Prospectus in Late September